CD274 and neoplasm: Through the upregulation of PD1/PD-L1 pathways, tumours expressing higher levels of PD-L1 seem to have a worse prognosis, presumably through generating the “brakes” to achieve negative co-stimulation in surrounding immune cells and achieving immune privilege.